For example, Tamoxifen, which was originally used to treat all breast cancers, is now known to be effective against tumors expressing hormone receptors (ERs and PRs), while Trastuzumab therapy is used to treat patients presenting an over-amplification of HER2 [13]. Here, ERBB2 is linked to breast cancer.